Cancer Clinical Trial
Official title:
Long-Term Retention of Prospectively Obtained Biospecimens
Background:
This protocol is designed to have samples from closing protocols transferred to this protocol
for long-term storage. The protocol is concerned with the retention of blood, plasma, serum,
CSF, aspirates, bone marrow, ascites fluid, urine, saliva, PBMCs, skin, mucosal, tumor and
healthy tissue samples from patients with cancer to support basic science and clinical
research activities of the Medical Oncology Branch and other intramural Laboratories and
Branches at the NIH Clinical Research Center and Center for Cancer Research.
Objectives:
To allow long-term storage of biospecimens collected during prospective clinical trials in
patients with various cancer phenotypes, as needed to support the research activities of the
Medical Oncology Branch and other Laboratories and Branches.
Eligibility:
Samples eligible for long-term retention must be from those who have signed consent for
storage and retention of biospecimens.
Design:
Acquired samples will be barcoded and associated data will be entered into an encrypted
computer software system, and securely maintained to protect patient identifiers. Samples are
retained and made available to the original PI, or other Investigators with the original PI's
permission, following submission and approval of a supplemental research protocol to the IRB
or OHSRP.
Background:
This protocol is designed to have samples from closing protocols transferred to this protocol
for long-term storage. The protocol is concerned with the retention of blood, plasma, serum,
CSF, aspirates, bone marrow, ascites fluid, urine, saliva, PBMCs, skin, mucosal, tumor and
healthy tissue samples from patients with cancer to support basic science and clinical
research activities of the Genitourinary Malignancies Branch (GMB) and other intramural
Laboratories and Branches at the NIH Clinical Research Center and Center for Cancer Research.
Objectives:
To allow long-term storage of biospecimens collected during prospective clinical trials in
patients with various cancer phenotypes, as needed to support the research activities of the
Genitourinary Malignancies Branch (GMB) and other Laboratories and Branches.
Eligibility:
Samples eligible for long-term retention must be from those who have signed consent for
storage and retention of biospecimens.
Design:
Acquired samples will be barcoded and associated data will be entered into an encrypted
computer software system, and securely maintained to protect patient identifiers. Samples are
retained and made available to the original Principal Investigator (PI), or other
investigators with the original PI's permission, following submission and approval of a
supplemental research protocol to the IRB or OHSRP.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
| Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
| Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
| Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
| Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
| Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
| Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
| Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
| Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
| Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
| Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
| Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
| Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
| Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
| Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
| Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
| Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|
||
| Recruiting |
NCT05318196 -
Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases
|